We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
29 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WELIREG belzutifan 40 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAGEVRIO molnupiravir 200 mg capsules bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe.
-
Prescription medicine registrationActive ingredients: belzutifan.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Australian public assessment report (AusPar)AusPAR for Vaxneuvance (pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed) for the prevention of pneumococcal disease.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.